Global Organ Transplant Rejection Medication Market Size study & Forecast, by Drug Class (Antibodies, Antimetabolites, Calcineurin Inhibitors, mTOR Inhibitors, Steroids), by Transplant Type (Kidney, Liver, Heart, Lung, Pancreas, Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Analysis, 2023-2030
Pigmentation Disorders Treatment Global Market Report 2023Including: 1) By Treatment Type: Topical Treatment; Dermabrasion; Chemical Peels; Laser Treatment; Phototherapy2) By Drugs: Calcineurin Inhibitors; Melanocyte-Stimulating Hormone3) By Type Of Disorder: Albinism; Vitiligo; Melasma; Post-Inflammatory Hyperpigmentation (PIH) Of Disorder4) By Route Of Administration: Oral; Topical5) By Distribution Channel: Dermatology Clinics; Aesthetic Clinics; Drugstores And Cosmetic Stores; E-CommerceCovering: AbbVie Inc.; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb; LOral S.A.
Market Overview:
The global ulcerative colitis market size reached US$ 7.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
Ulcerative colitis (…
Global Atopic Dermatitis Drugs Market is valued at approximately USD 12.71 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2029. Atopic dermatitis also known as eczema is a chronic, inf…
Global Immunosuppressants API Market By Method (Synthetic Chemistry, Peptide chemistry, Fermentation, Chromatographic purification), By Application (Autoimmune Disease, Organ Transplant), By Type (Corticosteroids, Janus Kinase Inhibitor, Calcineurin Inhibitors, mTOR Inhibitor, Others), By Product (Tablets, Capsules, Liquids, Injections), By APIs (Tacrolimus, Sirolimus, Everolimus, Mycophenolate Mofetil, Mycophenolate Sodium), By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others), By Region, Competition, Forecast & Opportunities, 2025
Global Ulcerative Colitis Market by Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immunosuppressant, Calcineurin Inhibitors, and Other Drug Types), Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), Regional Forecasts 2021-2027
The Dermatological Therapeutics market was valued at USD 30,316 million in 2020, and it is expected to reach USD 46,345 million by 2026, registering a CAGR of 8.95%, during the period.
Globally, due to high transmission rate of COVID-19, many countries a…
The Ulcerative Colitis Market is expected to register a CAGR of 5.3% during the forecast period.
COVID-19 has been a threat multiplier that affects all aspects of life. The medical and psycho-socioeconomic effects of the COVID-19 pandemic and pre-existin…